Benitec Biopharma
BNTC

Benitec Biopharma (BNTC) earnings history

Most recent quarter

Period end
Mar 31, 2025
EPS actual
−$0.24
EPS estimate
−$0.35
Revenue
$0.00
Reported
May 14, 2025

Earnings history

PeriodReportedEPS estimateEPS actualSurpriseRevenueFiling
Q3 2025May 14, 2025−$0.35−$0.24+31.09%$0.00SEC
Q2 2025Feb 14, 2025−$0.78−$0.33+57.46%$0.00SEC
Q1 2025Nov 14, 2024−$0.55−$0.48+12.73%$0.00SEC
Q4 2024Sep 26, 2024−$0.49$1.04+313.33%$0.00SEC
Q3 2024May 13, 2024−$0.78−$1.64−110.26%$0.00SEC
Q2 2024Feb 13, 2024−$0.39−$2.64−576.92%$0.00SEC
Q1 2024Nov 13, 2023−$0.51−$2.76−441.18%$0.00SEC
Q4 2023Sep 21, 2023−$3.23−$0.01+99.69%$15,000.00SEC
Q3 2023May 15, 2023−$3.40−$2.72+20.00%$54,000.00SEC
Q2 2023Feb 13, 2023−$1.87−$3.40−81.82%$14,000.00SEC
Q1 2023Nov 10, 2022−$3.15−$7.99−154.05%$0.00SEC
Q4 2022Sep 2, 2022−$4.76−$10.54−121.43%$0.00SEC
Q3 2022May 16, 2022−$7.48−$6.80+9.09%$48,000.00SEC
Q2 2022Feb 14, 2022$0.00−$10.03+0.00%$25,000.00SEC
Q1 2022Nov 15, 2021$0.00−$10.54+0.00%$0.00

Quarterly revenue

Q1 2022
$0.00
Q2 2022
$25,000.00
Q3 2022
$48,000.00
Q4 2022
$0.00
Q1 2023
$0.00
Q2 2023
$14,000.00
Q3 2023
$54,000.00
Q4 2023
$15,000.00
Q1 2024
$0.00
Q2 2024
$0.00
Q3 2024
$0.00
Q4 2024
$0.00
Q1 2025
$0.00
Q2 2025
$0.00
Q3 2025
$0.00

Frequently asked questions

  • When did Benitec Biopharma (BNTC) last report earnings?

    Benitec Biopharma last reported on May 14, 2025, covering fiscal Q3 2025.

  • Did BNTC beat earnings estimates?

    Yes. Benitec Biopharma reported EPS of −$0.24 for Q3 2025 against a −$0.35 estimate — a 31.09% beat.

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.